The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Antibiotic resistance management
Open accessAbstract
Antibiotic resistance is ‘bacteria changing in ways that reduce or eliminate the effectiveness of antibiotics’ [1]. These changes are due to bacterial evolution, and threaten the single greatest therapeutic advance in the history of medicine. Antibiotic resistance genes arose long ago in response to naturally occurring antibiotics. Modern medicine has driven further evolution of some of these genes. Resistance can also arise spontaneously by mutation. In bacteria, genes can be inherited or they can be acquired from non-relatives on mobile genetic elements like plasmids. This horizontal gene transfer (HGT) can occur between very different bacteria. Antibiotic use drives the evolution of resistance [2]. Resistant bacteria spread by natural selection when antibiotics fail to halt their reproduction while removing their drug-sensitive competitors. Antibiotic resistance management is an attempt to slow the spread of resistance by the judicious use of antibiotics, an important aim of antibiotic stewardship programs. One way the evolution of antibiotic resistance can be slowed is by minimizing the strength of natural selection for resistance genes. This means reducing antibiotic use. Don’t treat asymptomatic infections. Use antibiotics only where they can work. 70% of acute bronchitis cases are treated with antibiotics to no effect [3]. When treatment is necessary, use as little as possible. Decrease the need for antibiotic treatment with vaccines, hygiene, and isolation of infected patients. Prevent non-medical uses like growth promotion in farm animals. Reducing antibiotic use also limits selection for resistance in harmless bacteria that can donate genes to pathogens by HGT, as does targeting pathogens with narrow spectrum antibiotics. Another way to slow resistance evolution is to prevent pathogens acquiring resistance genes in the first place. In some cases, this can be done with high doses (dead bugs can’t evolve) or combination therapy (acquiring resistance to several drugs at once is unlikely). Bottom line: antibiotics should be used only when necessary and then, appropriately. What constitutes appropriate use of antibiotics can be controversial. For instance, dead bugs can’t acquire resistance, so aggressively killing pathogenic bacteria with antibiotics can retard resistance evolution. But aggressive treatment also maximizes the evolutionary advantage of already resistant pathogens or of non-target bacteria that can be a source of resistance genes. Consequently, treatments designed to minimize the rate of resistance acquisition might not be best when resistance is already present [4]. Other major research questions: (i) when do drug cocktails select for multidrug resistance faster than sequential monotherapies?, (ii) does repeated antibiotic use generate a microbiomic reservoir of resistance genes for future pathogens?, (iii) what properties of particular drugs make them more evolution-proof than others?, and (iv) is inappropriate antibiotic use the main evolutionary force undermining drug efficacy—or is it medically appropriate use?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
Read, A. F., Day, T., & Huijben, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100299108 · Cited by 242
Self-citationPopulation biological principles of drug-resistance evolution in infectious diseases
zur Wiesch, P. A., Kouyos, R., Engelstädter, J., Regoes, R. R., & Bonhoeffer, S. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70264-4 · Cited by 240
Antibiotic Prescribing for Adults With Acute Bronchitis in the United States, 1996-2010
Barnett, M. L., & Linder, J. A. (2014) · JAMA · doi:10.1001/jama.2013.286141 · Cited by 158
Cited by
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
The One Health Concept: 10 Years Old and a Long Road Ahead
Destoumieux-Garzón, D., Mavingui, P., Boetsch, G., Boissier, J., Darriet, F., Duboz, P., Fritsch, C., Giraudoux, P., Le Roux, F., Morand, S., et al. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00014 · Cited by 992
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Metadata
- Authors
- Read, A. F., & Woods, R. J.
- Venue
- Evolution, Medicine, and Public Health
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-28
- Volume
- 2014
- Issue
- 1
- Pages
- 147-147
- ISSN
- 2050-6201 (ISSN-L)
- OpenAlex
- W2111604015
- Cited by
- 302
- References
- 3
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibiotic resistance management. https://app.cochat.ai/papers/10.1093/emph/eou024
- The paper
- Read, A. F., & Woods, R. J. (2014). Antibiotic resistance management. Evolution, Medicine, and Public Health. https://doi.org/10.1093/emph/eou024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.